1392 related articles for article (PubMed ID: 7491703)
21. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
22. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
[TBL] [Abstract][Full Text] [Related]
23. Induction of specific tolerance to small-bowel allografts.
Orloff MS; Fallon MA; DeMara E; Coppage ML; Leong N; Cerilli J
Surgery; 1994 Aug; 116(2):222-8. PubMed ID: 8047988
[TBL] [Abstract][Full Text] [Related]
24. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
25. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
[TBL] [Abstract][Full Text] [Related]
26. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
[TBL] [Abstract][Full Text] [Related]
27. Donor-specific tolerance induction in composite tissue allografts.
Foster RD; Fan L; Neipp M; Kaufman C; McCalmont T; Ascher N; Ildstad S; Anthony JP; Niepp M
Am J Surg; 1998 Nov; 176(5):418-21. PubMed ID: 9874425
[TBL] [Abstract][Full Text] [Related]
28. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
Jankowski RA; Ildstad ST
Hum Immunol; 1997 Feb; 52(2):155-61. PubMed ID: 9077564
[TBL] [Abstract][Full Text] [Related]
29. A rodent model of in utero chimeric tolerance induction.
Yuh DD; Gandy KL; Hoyt G; Reitz BA; Robbins RC
J Heart Lung Transplant; 1997 Feb; 16(2):222-30. PubMed ID: 9059934
[TBL] [Abstract][Full Text] [Related]
30. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
31. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
32. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
Hayashi H; LeGuern C; Sachs DH; Sykes M
Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
[TBL] [Abstract][Full Text] [Related]
33. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
[TBL] [Abstract][Full Text] [Related]
34. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
[TBL] [Abstract][Full Text] [Related]
35. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
[TBL] [Abstract][Full Text] [Related]
36. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.
Gaines BA; Colson YL; Kaufman CL; Ildstad S
Exp Hematol; 1996 Jul; 24(8):902-13. PubMed ID: 8690049
[TBL] [Abstract][Full Text] [Related]
37. Induction of donor-specific tolerance to rat cardiac and small bowel allografts by intrathymic inoculation of donor T-cells.
Chowdhury NC; Fawwaz RA; Oluwole SF
J Surg Res; 1993 Apr; 54(4):368-74. PubMed ID: 8331931
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
39. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients.
Sykes M; Chester CH; Sundt TM; Romick ML; Hoyles KA; Sachs DH
J Immunol; 1989 Dec; 143(11):3503-11. PubMed ID: 2584703
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte chimerism in a full allogeneic composite tissue (rat-limb) allograft model prolonged with cyclosporine.
Hewitt CW; Black KS; Henson LE; Achauer BM; Nguyen JH
Transplant Proc; 1988 Apr; 20(2 Suppl 2):272-8. PubMed ID: 3259042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
